Physician

George T Keshelava, M.D.

According to 2025 Medicare claims, George Keshelava, M.D. (NPI: 1255541975) practices infectious disease in the Hammond, LA market, with the plurality of this provider's patient population coming from Tangipahoa, LA. This provider's primary affiliated billing organization is GEORGE KESHELAVA, MD LLC (NPI: 1932528486; TIN: 46-4901379) and primary practice location at 70403-1408.

Keshelava's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 351 traditional Medicare patients, billed 5,386 HCPCS/CPT codes, and received $347,782 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 473 prescription claims across 93 beneficiaries totaling $297,223 in drug costs, led by Genvoya (Elviteg/Cob/Emtri/Tenof Alafen). 2015 DME data shows 44 claims. Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $27,783 and ending at $297,223. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	615	6,568	$407,298
2016	734	7,016	$424,430
2017	671	7,585	$546,934
2018	687	7,347	$464,729
2019	641	6,628	$424,664
2020	556	6,873	$437,983
2021	435	6,066	$369,523
2022	464	6,609	$392,145
2023	434	5,894	$376,372
2024	351	5,386	$347,782

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	78	$27,783
2016	64	330	$602,601
2017	46	211	$154,036
2018	56	329	$427,297
2019	75	354	$325,025
2020	97	519	$515,207
2021	81	530	$427,049
2022	82	395	$298,758
2023	75	377	$407,114
2024	93	473	$297,223

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	44	$426
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	118	128	$138
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	239	305	$131
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	27	41	$62
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	236	2,592	$60
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	126	2,315	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	35	1,050	$135,355
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	15	450	$59,002
Daptomycin	Daptomycin	48	318	$31,026
Vancomycin Hcl	Vancomycin Hcl	70	447	$12,433
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	48	313	$8,782

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$25	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for George T. Keshelava, M.D.?

Tedicare shows public-source Medicare data for George T. Keshelava, M.D. (NPI 1255541975), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George T. Keshelava, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George T. Keshelava, M.D.?

George T. Keshelava, M.D. is linked to GEORGE KESHELAVA, MD LLC (billing NPI 1932528486) in the available physician profile data.

Does George T. Keshelava, M.D. have Open Payments data?

George T. Keshelava, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.